Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE2
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Condition: Head and Neck Squamous Cell Carcinoma
NCT06989671
SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.